The Parkinson’s disease (PD) therapeutic landscape is heavily genericized, leaving substantial unmet needs in neuroprotective ...

Parkinson's disease and ADHD are genetically linked, finds a brain study that could provide a roadmap for future treatment.

A team of Tel Aviv University researchers claims to have made progress in the path to treating Parkinson’s disease. The team found that a variant of a protein, caused by a genetic mutation, enhances ...

Parkinson’s Disease (PD) is a common brain disorder that affects movement and is most often linked with aging. It’s the second most common age-related brain disease, affecting millions worldwide.

Gene variant found linking people of African descent to higher Parkinson’s risk One million Americans live with Parkinson’s disease, a progressive condition that causes problems with body ...

Ahead, Dr. Khurana breaks down everything you need to know about Parkinson's disease, including early symptoms, what causes Parkinson's, and how Parkinson's disease is treated. Vikram Khurana ...

While Parkinson’s disease (PD ... These investigational agents target key mechanisms implicated in the pathophysiology of PD, ...

Scientists are learning more about the mysterious origins of Parkinson’s disease, and recent research suggests it may start ...

The pathophysiology of movement disorders ... Functional connectivity in the basal ganglia–thalamo–cortical circuit in Parkinson's disease and levodopa-induced dyskinesia.

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

Blind, Randomized, Placebo-controlled, Study of Bezisterim in Subjects with Early Parkinson’s Disease is now fully funded. Favorable capital market conditions last week enabled the company to raise ...